Cited 31 times in
Hepatitis B Virus X Protein Induced Expression of the Nur77 Gene
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김세종 | - |
dc.contributor.author | 박전한 | - |
dc.date.accessioned | 2016-02-19T11:24:02Z | - |
dc.date.available | 2016-02-19T11:24:02Z | - |
dc.date.issued | 2001 | - |
dc.identifier.issn | 0006-291X | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/143061 | - |
dc.description.abstract | Hepatitis B virus (HBV) X protein (HBx) plays an essential role in development of HBV-associated hepatocellular carcinoma (HCC). Recently, we reported that HBx induces Fas Ligand (FasL) expression, which may help HCC cells to evade host-immune surveillance. The aim of this study was to investigate the role of HBx in expression of Nur77, an orphan nuclear receptor implicated in the upregulation of FasL. When Chang X-34 expressing HBx under the control of a doxycycline-inducible promoter was examined, induction of Nur77 was observed following HBx expression. Blocking of Nur77 function by introduction of an antisense or a dominant negative mutant Nur77 significantly inhibited the induction of FasL, indicating that Nur77 plays critical roles in FasL expression. Further, a high-level expression of transcripts and DNA binding of Nur77 were observed in the HBV-integrated cell lines established from HCC patients that express HBx. These results suggested that Nur77 may contribute to leading the HBx-induced Fas/FasL signaling pathway which eliminates invading Fas-expressing lymphocytes. | - |
dc.description.statementOfResponsibility | open | - |
dc.format.extent | 1162~1168 | - |
dc.relation.isPartOf | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.subject.MESH | Carcinoma, Hepatocellular/genetics | - |
dc.subject.MESH | Carcinoma, Hepatocellular/metabolism* | - |
dc.subject.MESH | Carcinoma, Hepatocellular/virology | - |
dc.subject.MESH | DNA-Binding Proteins/biosynthesis* | - |
dc.subject.MESH | DNA-Binding Proteins/genetics | - |
dc.subject.MESH | DNA-Binding Proteins/physiology | - |
dc.subject.MESH | Fas Ligand Protein | - |
dc.subject.MESH | Hepatitis B/genetics | - |
dc.subject.MESH | Hepatitis B/metabolism* | - |
dc.subject.MESH | Hepatitis B/virology | - |
dc.subject.MESH | Hepatitis B virus/genetics | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Liver Neoplasms/genetics | - |
dc.subject.MESH | Liver Neoplasms/metabolism* | - |
dc.subject.MESH | Liver Neoplasms/virology | - |
dc.subject.MESH | Membrane Glycoproteins/biosynthesis | - |
dc.subject.MESH | Membrane Glycoproteins/genetics | - |
dc.subject.MESH | Mutation | - |
dc.subject.MESH | Nuclear Receptor Subfamily 4, Group A, Member 1 | - |
dc.subject.MESH | Oligonucleotides, Antisense/pharmacology | - |
dc.subject.MESH | Promoter Regions, Genetic | - |
dc.subject.MESH | RNA, Messenger/biosynthesis | - |
dc.subject.MESH | Receptors, Cytoplasmic and Nuclear | - |
dc.subject.MESH | Receptors, Steroid | - |
dc.subject.MESH | Trans-Activators/biosynthesis | - |
dc.subject.MESH | Trans-Activators/genetics | - |
dc.subject.MESH | Trans-Activators/metabolism | - |
dc.subject.MESH | Trans-Activators/pharmacology* | - |
dc.subject.MESH | Trans-Activators/physiology | - |
dc.subject.MESH | Transcription Factors/biosynthesis* | - |
dc.subject.MESH | Transcription Factors/genetics | - |
dc.subject.MESH | Transcription Factors/physiology | - |
dc.subject.MESH | Transcriptional Activation* | - |
dc.subject.MESH | Transfection | - |
dc.subject.MESH | Tumor Cells, Cultured | - |
dc.subject.MESH | Virus Integration | - |
dc.title | Hepatitis B Virus X Protein Induced Expression of the Nur77 Gene | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Microbiology (미생물학) | - |
dc.contributor.googleauthor | Mi-Ock Lee | - |
dc.contributor.googleauthor | Hyo-Jin Kang | - |
dc.contributor.googleauthor | Hyeseong Cho | - |
dc.contributor.googleauthor | Eui-Cheol Shin | - |
dc.contributor.googleauthor | Jeon Han Park | - |
dc.contributor.googleauthor | Se Jong Kim | - |
dc.identifier.doi | 10.1006/bbrc.2001.5910 | - |
dc.admin.author | false | - |
dc.admin.mapping | false | - |
dc.contributor.localId | A00603 | - |
dc.contributor.localId | A01641 | - |
dc.relation.journalcode | J00281 | - |
dc.identifier.eissn | 1090-2104 | - |
dc.identifier.pmid | 11700033 | - |
dc.identifier.url | http://www.sciencedirect.com/science/article/pii/S0006291X01959108 | - |
dc.contributor.alternativeName | Kim, Se Jong | - |
dc.contributor.alternativeName | Park, Jeon Han | - |
dc.contributor.affiliatedAuthor | Kim, Se Jong | - |
dc.contributor.affiliatedAuthor | Park, Jeon Han | - |
dc.rights.accessRights | not free | - |
dc.citation.volume | 288 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 1162 | - |
dc.citation.endPage | 1168 | - |
dc.identifier.bibliographicCitation | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, Vol.288(5) : 1162-1168, 2001 | - |
dc.identifier.rimsid | 38989 | - |
dc.type.rims | ART | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.